Epilepsy drugs

Companies that develop and sell medicines to treat epilepsy and seizures, including rare forms that start in childhood.
−6.7%
over 6 months · S&P 500 +2.6%

Key indicators

Health
49 / 100
Fragile
Solid
Up over 1 year
7 of 9
Volatility
72%
Calm
Choppy
Profitability
−865%
Low
High
Health and price: against the other tags.